This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Krajewska, M. Articles by Reed, J. C. Search for Related Content PubMed PubMed Citation Articles by Krajewska, M. Articles by Reed, J. C.

American Journal of Pathology, Vol 152, 1549-1561, Copyright © 1998 by American Society for Investigative Pathology

REGULAR ARTICLES

TRAF-4 expression in epithelial progenitor cells. Analysis in normal adult, fetal, and tumor tissues

M Krajewska, S Krajewski, JM Zapata, T Van Arsdale, RD Gascoyne, K Berern, D McFadden, A Shabaik, J Hugh, A Reynolds, CV Clevenger and JC Reed
Burnham Institute, La Jolla, CA 92037, USA.

TRAF-4 was discovered because of its expression in breast cancers and is a member of the tumor necrosis factor (TNF) receptor-associated factor (TRAF) family of putative signal-transducing proteins. In vitro binding assays demonstrated that TRAF-4 interacts with the cytosolic domain of the lymphotoxin-beta receptor (LT beta R) and weakly with the p75 nerve growth factor receptor (NGFR) but not with TNFR1, TNFR2, Fas, or CD40. Immunofluorescence analysis of TRAF-4 in transfected cells demonstrated localization to cytosol but not nucleus. Immunohistochemical assays of normal human adult tissues revealed prominent cytosolic immunostaining in thymic epithelial cells and lymph node dendritic cells but not in lymphocytes or thymocytes, paralleling the reported patterns of LT beta R expression. The basal cell layer of most epithelia in the body was very strongly TRAF-4 immunopositive, including epidermis, nasopharynx, respiratory tract, salivary gland, and esophagus. Similar findings were obtained in 12- to 18-week human fetal tissue, indicating a highly restricted pattern of expression even during development in the mammary gland, epithelial cells of the terminal ducts were strongly TRAF-4 immunopositive whereas myoepithelial cells and most of the mammary epithelial cells lining the extralobular ducts were TRAF-4 immunonegative. Of 84 primary breast cancers evaluated, only 7 expressed TRAF-4. Ductal carcinoma in situ (DCIS) lesions were uniformly TRAF-4 immunonegative (n = 21). In the prostate, the basal cells were strongly immunostained for TRAF-4, whereas the secretory epithelial cells were TRAF-4 negative. Basal cells in prostate hypertrophy (n = 6) and prostatic intraepithelial neoplasia (PIN; n = 6) were strongly TRAF-4 positive, but none of the 32 primary and 16 metastatic prostate cancer specimens examined contained TRAF-4-positive malignant cells. Although also expressed in some types of mesenchymal cells, these findings suggest that TRAF-4 is a marker of normal epithelial stem cells, the expression of which often ceases on differentiation and malignant transformation.

This article has been cited by other articles:

				A. N. Abell and G. L. Johnson MEKK4 Is an Effector of the Embryonic TRAF4 for JNK Activation J. Biol. Chem., October 28, 2005; 280(43): 35793 - 35796. [Abstract] [Full Text] [PDF]

				J. K. Sax and W. S. El-Deiry Identification and Characterization of the Cytoplasmic Protein TRAF4 as a p53-regulated Proapoptotic Gene J. Biol. Chem., September 19, 2003; 278(38): 36435 - 36444. [Abstract] [Full Text] [PDF]

				F. Henkler, B. Baumann, M. Fotin-Mleczek, M. Weingartner, R. Schwenzer, N. Peters, A. Graness, T. Wirth, P. Scheurich, J. A. Schmid, et al. Caspase-mediated Cleavage Converts the Tumor Necrosis Factor (TNF) Receptor-associated Factor (TRAF)-1 from a Selective Modulator of TNF Receptor Signaling to a General Inhibitor of NF-{kappa}B Activation J. Biol. Chem., August 1, 2003; 278(31): 29216 - 29230. [Abstract] [Full Text] [PDF]

				J. Kuai, E. Nickbarg, J. Wooters, Y. Qiu, J. Wang, and L.-L. Lin Endogenous Association of TRAF2, TRAF3, cIAP1, and Smac with Lymphotoxin beta Receptor Reveals a Novel Mechanism of Apoptosis J. Biol. Chem., April 11, 2003; 278(16): 14363 - 14369. [Abstract] [Full Text] [PDF]

				Y. C. Xu, R. F. Wu, Y. Gu, Y.-S. Yang, M.-C. Yang, F. E. Nwariaku, and L. S. Terada Involvement of TRAF4 in Oxidative Activation of c-Jun N-terminal Kinase J. Biol. Chem., July 26, 2002; 277(31): 28051 - 28057. [Abstract] [Full Text] [PDF]

				J. Y. Chung, Y. C. Park, H. Ye, and H. Wu All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction J. Cell Sci., February 15, 2002; 115(4): 679 - 688. [Abstract] [Full Text] [PDF]

				J. M. Zapata, M. Krajewska, S. Krajewski, S. Kitada, K. Welsh, A. Monks, N. McCloskey, J. Gordon, T. J. Kipps, R. D. Gascoyne, et al. TNFR-Associated Factor Family Protein Expression in Normal Tissues and Lymphoid Malignancies J. Immunol., November 1, 2000; 165(9): 5084 - 5096. [Abstract] [Full Text] [PDF]

				H. Shiels, X. Li, P. T. Schumacker, E. Maltepe, P. A. Padrid, A. Sperling, C. B. Thompson, and T. Lindsten TRAF4 Deficiency Leads to Tracheal Malformation with Resulting Alterations in Air Flow to the Lungs Am. J. Pathol., August 1, 2000; 157(2): 679 - 688. [Abstract] [Full Text] [PDF]

				J. M. Zapata, S.-i. Matsuzawa, A. Godzik, E. Leo, S. A. Wasserman, and J. C. Reed The Drosophila Tumor Necrosis Factor Receptor-associated Factor-1 (DTRAF1) Interacts with Pelle and Regulates NFkappa B Activity J. Biol. Chem., April 14, 2000; 275(16): 12102 - 12107. [Abstract] [Full Text] [PDF]

				W. R. Force, A. A. Glass, C. A. Benedict, T. C. Cheung, J. Lama, and C. F. Ware Discrete Signaling Regions in the Lymphotoxin-beta Receptor for Tumor Necrosis Factor Receptor-associated Factor Binding, Subcellular Localization, and Activation of Cell Death and NF-kappa B Pathways J. Biol. Chem., April 6, 2000; 275(15): 11121 - 11129. [Abstract] [Full Text] [PDF]

				G. S. Pryhuber, H. L. Huyck, R. J. Staversky, J. N. Finkelstein, and M. A. O'Reilly Tumor Necrosis Factor-alpha -Induced Lung Cell Expression of Antiapoptotic Genes TRAF1 and cIAP2 Am. J. Respir. Cell Mol. Biol., February 1, 2000; 22(2): 150 - 156. [Abstract] [Full Text]

				X. Ye, P. Mehlen, S. Rabizadeh, T. VanArsdale, H. Zhang, H. Shin, J. J. L. Wang, E. Leo, J. Zapata, C. A. Hauser, et al. TRAF Family Proteins Interact with the Common Neurotrophin Receptor and Modulate Apoptosis Induction J. Biol. Chem., October 15, 1999; 274(42): 30202 - 30208. [Abstract] [Full Text] [PDF]

				E. Leo, K. Welsh, S.-i. Matsuzawa, J. M. Zapata, S. Kitada, R. S. Mitchell, K. R. Ely, and J. C. Reed Differential Requirements for Tumor Necrosis Factor Receptor-associated Factor Family Proteins in CD40-mediated Induction of NF-kappa B and Jun N-terminal Kinase Activation J. Biol. Chem., August 6, 1999; 274(32): 22414 - 22422. [Abstract] [Full Text] [PDF]

				C. Tomasetto, C.-H. Regnier, M.-C. Rio, M. Krajewska, S. Krajewski, and J. C. Reed TRAF-4 Expression in Breast Carcinomas Am. J. Pathol., December 1, 1998; 153(6): 2007 - 2008. [Full Text] [PDF]

				J. M. Zapata, K. Pawlowski, E. Haas, C. F. Ware, A. Godzik, and J. C. Reed A Diverse Family of Proteins Containing Tumor Necrosis Factor Receptor-associated Factor Domains J. Biol. Chem., June 22, 2001; 276(26): 24242 - 24252. [Abstract] [Full Text] [PDF]